Company intelligence / Profile preview

Azienda Farmaceutica

Sant'Egidio Alla Vibrata, Abruzzo, Italyaziendafarmaceuticaitaliana.it ↗

Ownership: Private
Development stage: Commercial

Overview

Azienda Farmaceutica Italiana is an active Italian pharmaceutical company focused on developing innovative drugs and medical devices. Its flagship product, Hepilor®, is a mucosal defense agent for gastrointestinal disorders, now being commercialized in Latin America through a partnership with TannerLAC. The company emphasizes research-driven innovation and compliance with high quality standards.

Therapeutic areas: Gastroenterology
Modalities: Small molecules (drugs)Medical devices
Industry: Biotech

Drug pipeline

1 asset

Hepilor

Commercial

Indications: Gastrointestinal mucosal protection and repair

Partnerships

TannerLAC/Tanner Pharma Group (Latin American commercialization partner for Hepilor®)PB Pharma Group (support partner for international expansion)

Beyond the preview

Go deeper on Azienda Farmaceutica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azienda Farmaceutica.

Explore the full profile